Secondary tabs
Contact details
Gilles Paubert
Main
Charlotte Renaudat
Alternate
Publications
Data source publications
- Rassy, E. et al. Association of Adherence to Endocrine Therapy Among Patients With Breast Cancer and Potential Drug-Drug Interactions. JAMA Netw. Open 5, e2244849 (2022)
- Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network. Cederholm S1, Hill G, Asiimwe A, Bate A, Bhayat F, Persson Brobert G, Bergvall T, Ansell D, Star K, Norén GN. Drug Saf. 2015 Jan;38(1):87-100. doi: 10.1007/s40264-014-0251-y.
- Childhood epilepsy recorded in primary care in the UK. Meeraus WH, Petersen I, Chin RF, Knott F, Gilbert R. Arch Dis Child. 2013 Mar;98(3):195-202. doi: 10.1136/archdischild-2012-302237. Epub 2013 Jan 23.
- Antonazzo, I. C. et al. Time trends in the incidence of essential tremor: Evidences from UK and France primary care data. Front. Neurol. 13, (2022).
- 2,000 publications using THIN data
Studies
List of studies that have been conducted using the data source
- Calcium channel blocker treatments and cancer risk. A methodological protocol to compare the results between databases, across designs: Evaluation of the impact of design/database/population differences on the outcome of the studied association
- Use of benzodiazepines and risk of hip/femur fracture. A methodological comparison across data sources and epidemiological design.
- Use of inhaled long acting beta2 adrenoceptor agonists and the risk for Acute Myocardial Infarction (AMI). A methodological comparison across data sources and epidemiological design
- Use of antiepileptics and risk of suicidality. An exploratory study using the UK General Practice Research Database (GPRD) and data from the Danish registries with an evaluation of available data from further European data sources.
- Pattern of use of Human Growth Hormone (Somatropin) in the United Kingdom general practice setting: A Drug Utilization Study in The Health Improvement Network (THIN) database (Somatropin use in routine clinical practice in UK)
- EMA study on prescribing of codeine to children and adolescents for cough and cold
- Assessment of the safety of LABAs in asthma in routine care by combining healthcare databases and direct patient follow-up (ASTRO-LAB)
- Cardiac profile of patients using rosiglitazone-containing anti-diabetes medicines: a study using the THIN database
- EMA Self-Controlled Case Study of Fluoroquinolones and Retinal Detachment in The Health Improvement Network database
- Retrospective Case‐Control Studies of Rare Adverse Events Associated with Intranasal Steroids (201077)
- An Observational Post-Authorization Safety Study (PASS) of MOVENTIG® (Naloxegol) Drug Utilization in Selected European Populations
- An Observational Post-Authorization Safety Study (PASS) of MOVENTIG® (Naloxegol) Among Patients Aged 18 Years and Older Treated with Opioids Chronically
- A cohort study with a nested case control analysis on the association between acid-suppressing drugs and seizures using THIN database in the UK (Acid suppressing Drug Seizure Epidemiology Study)
- A cohort study on the association between acid-suppressing drugs in pregnancy and asthma in the offspring (Acid-suppressing Drugs Pregnancy Asthma Offspring)
- A Nested Case-control Post-authorization Safety Study of Etoricoxib and Other Non-steroidal Anti-inflammatory Therapies in a Cohort of Patients with Ankylosing Spondylitis (AS) in the UK, France and Germany (MK-0663-163)
- Risk of cardiac valve disorders associated with the use of biphosphonates (Cardiac valve disorders and biphosphonate use)
- Patterns and Determinants of Use of Oral Contraceptives in the European Union (Use of OC in the EU)
- Arrhythmogenic Potential of Drugs (ARITMO) project
- ADVANCE POC I Risk pillar - Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case: Incidence rates of safety outcomes of whole-cell pertussis and acellular pertussis vaccines in pre-school children
- ADVANCE POC Study Protocol - Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case. Coverage rates of acellular and whole-cell pertussis-containing vaccines in preschool children (ADVANCE Coverage POC)
- Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case: Incidence rates of pertussis and pertussis related outcomes of whole-cell pertussis and acellular pertussis vaccines in pre-school children (benefit study on pertussis vaccination)
- Identification of type 2 diabetes cases in a set of databases participating to the EMIF project
- European Program of Post-Authorization Safety Studies for Protelos®/Osseor® through EU-ADR Alliance
- Post-licensure observational safety study of specific outcomes after Optaflu vaccination among adults in The Health Improvement Network (THIN) database of routine UK primary care records (V58_30OB (FLUPASS1))
- An Observational Drug Utilization Study of SYCREST® (asenapine) in the United Kingdom (P08308)
- An Observational Post-Authorization Safety Surveillance (PASS) Study of SYCREST® (asenapine) among Patients aged 18 and older Diagnosed with Bipolar Disorder (P08307)
- Cilostazol Drug Utilisation Study
- Cohort Study of Psychiatric Adverse Events Following Exposure to Levonorgestrel-Containing Intrauterine Devices in UK General Practice
- Indications for systemic fluoroquinolone prescribing in Europe: a descriptive population based study
- Estimating prevalence and incidence of acute myocardial infarction in a set of heterogeneous sources of observational health data collaborating in the EMIF Platform
- Use of antidepressants and risk of hip/femur fracture. A methodological comparison across data sources and epidemiological design
- The risk of acute liver injury associated with the use of antibiotics. A methodological comparison across epidemiological data sources
- Tramadol prescribing: a drug utilisation study using electronic data from France, Germany and the UK
- Risk of peripheral neuropathy with systemic fluoroquinolone exposure: population-based nested case-control study
- Risk of tendon rupture with systemic fluoroquinolone exposure: nested case-control study
- Drug utilization study of cyproterone/ethinylestradiol (Diane®-35 and generics) in the Netherlands, UK and Italy
- Loperamide and the risk of Brugada syndrome
- Comparative Assessment of VTE and Other Risks among Patients with Rheumatoid Arthritis treated with Baricitinib versus Tumor Necrosis Factor Inhibitors: A Multi-database Observational Cohort Study
- Use of products containing oestrogens alone and oestrogens in combination with progestogens (not contraceptives) between 2000 and 2014 in France, Germany and the UK
- The comparative safety of first-line conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) used for the treatment of rheumatoid arthritis: protocol for a multi-database real-world cohort study
- Utilisation disease-modifying anti-rheumatic drugs (DMARDs) used for the treatment of rheumatoid arthritis: protocol for a multi-database real-world cohort study
- Non-interventional study with Binosto 70 mg effervescent tablets once weekly investigating gastro-intestinal events and medication errors (Gastro-PASS)
- Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?
- Ability of primary care health databases to assess medicinal products discussed by the European Union Pharmacovigilance Risk Assessment Committee (CAPs and NAPs in primary EHDs)
- Association between hydrochlorothiazide exposure and skin and lip cancer: a series of populationbased nested case-control studies
- Prescribing of paracetamol in patients with chronic renal failure A Drug Utilisation Study (Paracetamol doses in renal failure)
- Suicide and suicidality after exposure to finasteride (Suicidality with finasteride)
- Pattern of use of Direct Oral Anticoagulants in Non-valvular Atrial Fibrillation patients in UK general practices
- Drug Utilisation Study of conjugated oestrogens/bazedoxifene (CE/BZA) in the European Union (EU)
- Pharmacological risk factors for COVID-19 infection: a matched prospective cohort study of patients in primary care
- Delayed Denosumab Injections and Fractures Risk Among Subjects with Osteoporosis
- Hydroxychloroquine safety and potential efficacy as an antiviral prophylaxis in light of potential wide-spread use in COVID-19: a multinational, large-scale network cohort and self-controlled case series study
- Psychosis and psychotic disorders” and “Depression and suicide/self-injury” following exposure to Hydroxychloroquine and chloroquine
- Multinational database cohort study to assess RMP specified safety outcomes in association with indacaterol/glycopyrronium bromide in Europe
- Multinational, multi-database cohort study to assess adverse cardiovascular and cerebrovascular outcomes and mortality in association with inhaled NVA237 in Europe (NVA237 PASS)
- Multinational, multi-database drug utilization study of inhaled NVA237 in Europe (NVA237 DUS)
- Ranitidine and other histamine H2-receptor antagonists – a drug utilisation study
- Multinational, multi-database drug utilization study of indacaterol/glycopyrronium bromide in Europe
- Depression following exposure to anastrozole
- Incidence rates of adverse events of special interest: Guillain-Barré syndrome and Bell’s palsy
- Study of utilisation of combined hormonal contraceptives in Europe
- Post-licensure observational safety study after meningococcal B vaccine 4CMenB (Bexsero®) vaccination in routine UK care
- Post-authorization safety Electronic Medical Records database retrospective cohort study of new users of inhaled UMEC/VI or new users of inhaled UMEC in the primary care setting
- Adverse ReNal OuTcomEs in patients with NoN-Valvular Atrial fibrillation treated with Rivaroxaban or Vitamin K Antagonists (ANTENNA)
- Pancreatic Cancer and Thyroid Cancer Risks with Dulaglutide Treatment
- Report on PRAC Pilot on Rapid Data Analytics
- Rapid Data Analysis – Systemic fluoroquinolones and thrombotic thrombocytopenic purpura (TTP)
- Cohort Study of the Relative Incidence of Major Cardiovascular Events Among Patients Initiating Prucalopride Versus a Matched Comparator Cohort
- Comparative risk of the incident cancer between histamine-2 receptor antagonists (Risk of cancer between H2RAs)
- Post-authorisation Safety Study to Evaluate the Long-term Safety of Dexamfetamine (Amfexa) (PASS for dexamfetamine)
- A pharmacoepidemiological study of Rivaroxaban use and potential adverse outcomes in routine clinical pratice in the United Kingdom
- Safety and Effectiveness of Rivaroxaban and Apixaban compared to warfarin in non-valvular atrial fibrillation patients in the routine clinical practice in the UK (SiERRA UK)
- Trends in prescriptions of valproate and valpromide for bipolar disorder in IMS France and IMS Germany between 2010 and June 2016 and in UK THIN between 1999 and 2015
- Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation in the UK
- A pharmacoepidemiological study on the risk of bleeding in new users of low-dose aspirin (ASA) in The Health Improvement Network (THIN), UK (EPISAT)
- Systemic glucocorticoids in the treatment of COVID-19 and risks of adverse outcomes in COVID-19 patients in the primary and secondary care setting (Corticosteroids in COVID19)
- Incidence of Central Retinal Artery Occlusion in the Neovascular Age-related Macular Degeneration Population (RAO in neovascular AMD)
- Drug Utilisation Study of Intuniv® (guanfacine extended release) in European Countries, Study protocol I: Database study (Intuniv data base study Europe)
- Incidence rates of morphoea, systemic sclerosis and scleroderma
- ENSTILAR RWE STUDY, IN FRENCH EMR DATABASE (THIN®)
- Incidence rates of vulval ulceration following Comirnaty vaccine
- Incidence rates of pemphigus and pemphigoid following COVID-19 vaccines
- Population incidence rates of pemphigoid in six European countries
- Prevalence of palmoplantar psoriasis and pustular psoriasis in children
- Prevalence of Acute Liver Injury
- Incidence of phimosis and paraphimosis in patients treated with SGLT2 inhibitors
- Evidence in real world for Trixeo® Aerosphere™ Initiation in COPD (ENARXI)
- An Active Surveillance Study to Monitor the Real-World Long-term Safety of Somatrogon Among Paediatric Patients in Europe